Stay updated with breaking news from Universal Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Frederic Chereau named Chairman of the Board - Seasoned entrepreneur, Dr Claudia Mitchell, appointed Non-executive Director PARIS, Oct. 20, 2022 /PRNewswire/ -- Coave Therapeutics
Ikena Oncology (NASDAQ:IKNA – Get Rating) and Adaptimmune Therapeutics (NASDAQ:ADAP – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership and earnings. Risk and Volatility Ikena Oncology has a beta of […]
Cross-linked news, and information resources about PhaRMA
Fred Hutch, Univ. of Washington biotech spinout Ensoma launches with $70M in funding February 11, 2021 at 9:15 am Dr. Hans-Peter Kiem of the Fred Hutchinson Cancer Research Center. (Fred Hutch Photo) New spinout: Boston-based biotech startup Ensoma launched Thursday and announced a $70 million Series A funding round. The company is built on technology developed over two decades by Seattle researchers Dr. Hans-Peter Kiem of the Fred Hutchinson Cancer Research Center and Dr. André Lieber of the University of Washington School of Medicine. The company will be based in Boston because the city â€...